神经血管炎症与卒中溶栓治疗的并发症
本综述总结tPA(组织型纤溶酶原激活剂)在卒中患者及实验性卒中模型中诱导的免疫细胞显著改变,认为缺血诱导的细胞死亡触发的神经炎症被tPA加剧,损害神经血管完整性和微循环,导致出血转化,并讨论通过将免疫细胞与神经血管单元解耦联来减轻溶栓相关出血转化的当前和未来方法。
要点
- tPA迅速动员免疫细胞经脑血管外渗至脑实质,加剧神经血管炎症和组织损伤。
- 缺血诱导的细胞死亡触发神经炎症,tPA加剧该炎症,损害神经血管完整性和微循环,导致出血转化。
- 通过将免疫细胞与神经血管单元解耦联来减轻溶栓相关出血转化是当前和未来的研究方向。
核心结论
- 由缺血诱导的细胞死亡触发并被tPA加剧的神经炎症损害神经血管完整性和微循环,导致出血转化。
研究设计与样本
- 综述,总结tPA在卒中患者及实验性卒中模型中诱导的免疫细胞显著改变。
主要发现
- tPA迅速动员免疫细胞经脑血管外渗至脑实质,加剧神经血管炎症和组织损伤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Intravenous thrombolysis via tPA (tissue-type plasminogen activator) is the only approved pharmacological treatment for acute ischemic stroke, but its benefits are limited by hemorrhagic transformation. Emerging evidence reveals that tPA swiftly mobilizes immune cells which extravasate into the brain parenchyma via the cerebral vasculature, augmenting neurovascular inflammation, and tissue injury. In this review, we summarize the pronounced alterations of immune cells induced by tPA in patients with stroke and experimental stroke models. We argue that neuroinflammation, triggered by ischemia-induced cell death and exacerbated by tPA, compromises neurovascular integrity and the microcirculation, leading to hemorrhagic transformation. Finally, we discuss current and future approaches to attenuate thrombolysis-associated hemorrhagic transformation via uncoupling immune cells from the neurovascular unit.
引用
- Liu Q, Shi K, Wang Y, et al. Neurovascular Inflammation and Complications of Thrombolysis Therapy in Stroke. Stroke. 2023. PMID: 37675612. doi:10.1161/STROKEAHA.123.044123
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。